Medtronic plans to launch the system across select clinical and academic centres in the country starting this year.

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the companies' partnership.

Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump.

Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable ...

Medtronic (MDT) has submitted 510(k) applications to the FDA seeking clearance for an interoperable pump. FDA clearance of this pump would pave ...

Medtronic's recent regulatory approvals should bode well for non-GAAP EPS growth in the coming years. Read why I am ...

Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Medtronic has received clearance from the U.S. Food and Drug Administration for the Simplera Sync sensor for use with the MiniMed 780G system.

Notably, Medtronic holds the esteemed designation of a Dividend Aristocrat for investors who prioritize reliability. This ...

Medtronic plc’s diabetes unit posted another win with the U.S. FDA approval of the Simplera continuous glucose monitoring sensor for use with the Minimed 780G pump system, helping the company catch up ...

Medtronic has secured a green light from the FDA to connect its latest automated insulin pump with its newest continuous ...